In ambulatory patients with HFrEF receiving contemporary GDMT, it is not convincing evidence that the neutral effect of vericiguat on cardiovascular death or first HF hospitalization was modified by GDMT class, dose attainment, or overall intensity, in a cohort with very high background GDMT use and limited power for i...
Justin A. Ezekowitz, J. Butler, Derek Cyr et al.· European Journal of Heart Fa...· 0 citations
Mechanistically, visceral adiposity, systemic inflammation, immunometabolic dysregulation, structural remodeling, and accelerated cardiac aging converge to drive HFpEF across Asian patients, often at lower body mass index thresholds than recognized in Western models.
E. Balasa, F. Capone, A. Vacca et al.· 0 citations
Mechanistically, visceral adiposity, systemic inflammation, immunometabolic dysregulation, structural remodeling, and accelerated cardiac aging converge to drive HFpEF across Asian patients, often at lower body mass index thresholds than recognized in Western models.
E. Balasa, F. Capone, A. Vacca et al.· JACC: Asia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.